Financial Performance - Campine reported exceptional growth in H1 2025, with revenue more than doubling to €384 million from €169 million in H1 2024 [1] - EBITDA nearly tripled to €53.4 million, setting a new record for the first six months [1] Specialty Chemicals Division - Revenue for the Specialty Chemicals division rose to €293 million, four times higher than in 2024 (€74 million) [2] - Growth was primarily driven by antimony trioxide sales, with Campine becoming the global market leader following Chinese export restrictions at the end of 2024 [2] - EBITDA in this division increased from €6.0 million to €36.6 million [3] Circular Metals Division - Revenue in the Circular Metals division grew slightly to €114.4 million, a 2% increase [3] - The Metals Recovery unit saw revenue increase by more than 50%, driven by higher prices for gold, silver, and antimony [3] - EBITDA in this division rose from €13.7 million to €16.8 million, supported by lower purchase prices for battery scrap [4] Outlook for 2025 - Campine expects a record year, with EBITDA likely exceeding €80 million [5] - High profitability in Specialty Chemicals is anticipated to continue in the second half, despite a slight global decline in ATO demand [5] - The Circular Metals division continues to benefit from lower battery scrap costs, offsetting lower LME sales prices [5] Acquisition Plans - Campine is awaiting regulatory approval for the acquisition of three French Ecobat factories, which could further impact 2025 results [6]